The sellers and distributors of chemical components of Fen-Phen were not entitled to summary judgment on any of five grounds. Fisher v. Professional Compounding Centers of America et al, No. CV-S-01-1031-PMP-PAL, U.S. District Court for the District of Nevada, March 29, 2004.

Wanda Fisher suffered heart problems after ingesting the drug Fen-Phen. She sued, among others, defendant companies Alfa and PCCA. Each party moved for summary judgment, and the district court denied the motions.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]